FDA approves double-chin shot

California-based Kythera (pronounced KEE-ther-ah) hopes to use the drug to position itself as a medical “aesthetics” company – think cosmetic procedures akin to the widespread use of Botox.

The company says it will be available in June, after a training program.

“Once physicians are trained, they will be able to purchase Kybella and treat their patients,” a spokesman told NBC News.